Preparing for Pharmaceutical Tariffs: What Industry Can Do To Mitigate Supply Chain Risks

Taking the Pulse of BioPharma: The Industry Today and Trends of Tomorrow

Research Reveals Persistent Drug Pricing Distortions from PBM-Owned Pharmaceutical Companies

This summer, we launched a new research work that examined the costs yielded by a reborn and evolved species of the prescription drug supply

Why AI in healthcare supply chain management is an overlooked opportunity

AI performs best where a problem is well-defined, data-intensive, repetitive and operates at a scale that exceeds human tracking capacity. T

How far will EU push for fairer trade with China?

Strengthening rules on pharmaceutical and chemical trade could protect critical industries

US companies' caution higher tariffs may hit manufacturing push

Indian industry pushes back against USTR’s Section 301 tariff plan

FICCI, CII, ACMA, SEAI argue blanket duties lack an evidence base and risk disrupting integrated US-India supply chains